Hematopoietic Stem Cell Therapy for Wiskott–Aldrich Syndrome: Improved Outcome and Quality of Life

The Wiskott–Aldrich syndrome (WAS) is an X-linked disorder caused by mutations in the WAS gene resulting in congenital thrombocytopenia, eczema, recurrent infections and an increased incidence of autoimmune diseases and malignancies. Without curative therapies, affected patients have diminished life...

Descripción completa

Detalles Bibliográficos
Autores principales: Mallhi, Kanwaldeep K, Petrovic, Aleksandra, Ochs, Hans D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8206065/
https://www.ncbi.nlm.nih.gov/pubmed/34149291
http://dx.doi.org/10.2147/JBM.S232650

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8206065/
https://www.ncbi.nlm.nih.gov/pubmed/34149291
http://dx.doi.org/10.2147/JBM.S232650

Ejemplares similares